Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Biopharmaceuticals Market to Reach USD 113,300 Million by 2026 at CAGR 4.7% - Valuates Reports

This image opens in the lightbox

News provided by

Valuates Reports

29 Apr, 2021, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

BANGALORE, India, April 29, 2021 /PRNewswire/ -- The Biopharmaceuticals Market is Segmented by Type (Monoclonal Antibodies, Interferon, Colony-Stimulating Factor, Erythropoietin, Insulin, Vaccines, Growth Hormones, Others), by Application (Tumor, Diabetes, Cardiovascular, Hemophilia, Others). The report covers global opportunity analysis and industry forecast from 2021 to 2026. It is published on Valuates Reports in the Pharmaceuticals & Biotech Category.

The global Biopharmaceuticals market is projected to reach USD 113,300 Million by 2026, from USD 82,330 Million in 2019, at a CAGR of 4.7% during the forecast period 2021-2026.

Major factors driving the growth of the global biopharmaceuticals market are:

  • Growing geriatric population, rising chronic diseases, and increasing acceptance in the healthcare industry.
  • Benefits such as highly effective and potent action, fewer side effects, and the potential to actually cure diseases rather than merely treat the symptoms are expected to drive the growth of the biopharmaceuticals market.

View Report Details Before Purchasing: https://reports.valuates.com/market-reports/QYRE-Auto-22J2409/global-biopharmaceuticals

TRENDS INFLUENCING THE GROWTH OF BIOPHARMACEUTICALS MARKET SIZE:

The global population of the elderly is rapidly growing. This rise is propelling the global biopharmaceuticals market size forward, as the elderly population is more susceptible to illness due to poor immunity and long recovery times.

Furthermore, the rising prevalence of chronic diseases as a result of unhealthy lifestyles, poor diets, excessive alcohol intake, and a lack of physical activity are all contributing factors to the rise of biopharmaceutical market size. Many pharmaceutical firms are concentrating their efforts on creating more successful treatments for life-threatening illnesses and encouraging people to live healthy lives with fewer disabilities.

The possibility of side effects associated with certain small-molecule therapeutics and invasive surgical procedures is driving up market demand for biopharmaceuticals. Biopharmaceuticals drugs structurally mimic compounds found within the body and are produced using biotechnologies. These have the potential to cure diseases rather than merely treat symptoms and have fewer side effects because of their specificity. Moreover, because of their efficacy against autoimmune disorders and cancer, as well as their improved mode of action, biopharmaceuticals are expected to replace conventional small molecule drugs in the healthcare industry.

Increasing healthcare investments around the world are precipitating an increase in R&D for biopharmaceuticals. The increased R&D activity is expected to lead to the development of new and more efficient biopharmaceutical products. Thus the increase in healthcare investment is expected to create lucrative growth opportunities for the biopharmaceuticals market.

Request a Sample Copy of the Report For Growth & Trends Analysis on Biopharmaceuticals Market: https://reports.valuates.com/request/sample/QYRE-Auto-22J2409/Global_Biopharmaceuticals_Market

BIOPHARMACEUTICALS MARKET SHARE ANALYSIS

The Monoclonal Antibodies Segment is expected to be one of the major contributors to the biopharmaceuticals market share. The rapid growth of the segment is due to the active use of monoclonal antibodies and antibody derivatives in therapeutics. Monoclonal antibodies have therapeutic uses in cancer, rheumatoid arthritis, multiple sclerosis, and cardiovascular diseases, among others.

Based on region, North America is expected to be one of the major contributors to the biopharmaceuticals market share. The biopharmaceuticals market in North America is being driven by the rising burden of chronic disease and increased investment in research and development activities in the United States. The United States is known as the world's life sciences innovation capital, and it is active in global capital investments in biopharmaceuticals companies in their early stages.

Inquire for Regional/Country: https://reports.valuates.com/request/regional/QYRE-Auto-22J2409/Global_Biopharmaceuticals_Market

Top Major KeyPlayers in the Biopharmaceuticals Industry

  • Roche
  • Amgen
  • AbbVie
  • Sanofi-Aventis
  • Johnson & Johnson
  • Pfizer
  • Novo Nordisk
  • Eli Lilly
  • Novartis
  • Merck
  • Others

Biopharmaceuticals Market Breakdown Data by Type

  • Monoclonal Antibodies
  • Interferon
  • Colony-Stimulating Factor
  • Erythropoietin
  • Insulin
  • Vaccines
  • Growth Hormones
  • Others

Biopharmaceuticals Market Breakdown Data by Application

  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Others

Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-22J2409&lic=single-user

Buy Now for Enterprise License + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-22J2409&lic=enterprise-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the comment Section to know about our subscription plans.

SIMILAR REPORTS

-  The global Biopharmaceuticals Logistics market size is projected to reach USD 80180 Million by 2026, from USD 76940 Million in 2020, at a CAGR of 3.9% during 2021-2026. Air shipping segment is expected to dominate the biopharmaceuticals logistics market. The growth of the air shipping segment is due to the fact that air freight is the quickest method of transporting pharmaceutical goods with minimal loss or degradation, which is ideal for temperature-sensitive vaccines and essential biologic drugs. However, since air shipping has a volume cap, sea shipping and land shipping is predicted to outperform air shipping in terms of volume growth during the forecast period.

-  Pet Biopharmaceuticals Market contains segmentation By Type (Antiparasitic, Biological Products, Antibacterial, Others) By Application (Prevention, Treatment) and Regional Opportunity Analysis and Industry Forecast.

-  Biopharmaceuticals Excipients Market contains segmentation By Type (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Other) By Application (Biopharmaceutical Downstream, Biopharmaceutical Upstream) and Regional Opportunity Analysis and Industry Forecast.

-  The Preclinical Tomography System for Biopharmaceuticals Market contains segmentation By Type (CT, SPECT, Others) By Application (Hospital, Research Institute, Other) and Regional Opportunity Analysis and Industry Forecast.

-  Cancer Biopharmaceuticals Market contains segmentation By Type (Biologics, Biosimilars) By Application (Liquid Cancers, Solid Cancers) and Regional Opportunity Analysis and Industry Forecast.

-  Pharmaceutical Contract Manufacturing & Contract Market contains segmentation By Type (Manufacturing, Research) By Application (Small Medium Enterprise, Large Enterprise) and Regional Opportunity Analysis and Industry Forecast.

-  Single Use Technologies for Biopharmaceuticals Market contains segmentation By Type (Single-use Bioreactors, Membrane Adsorbers, Media Bags, Bioprocess Containers, Others) By Application (Contract Manufacturing Organizations, Biopharmaceutical Manufacturers) and Regional Opportunity Analysis and Industry Forecast.

-  Pharmaceutical Drug Delivery Devices Market contains segmentation By Type (Oral, Pulmonary, Injectable, Topical, Other) By Application (Cancer, Diabetes, Other) and Regional Opportunity Analysis and Industry Forecast.

To see the full list of related reports on the Biopharmaceuticals

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources

CONTACT US:

Valuates Reports
sales@valuates.com 
For U.S. Toll-Free Call  +1-(315)-215-3225
For IST Call  +91-8040957137
WhatsApp : +91 9945648335
Website: https://reports.valuates.com 
Follow on Twitter - https://twitter.com/valuatesreports 
Follow on Linkedin - https://in.linkedin.com/company/valuatesreports 
Follow on Facebook - https://www.facebook.com/valuatesreports

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg 

Modal title

Also from this source

Microphysiological System Market Soars: USD 148M in 2024 to USD 1134M by 2031 at 34.3% CAGR | Valuates Reports

Microphysiological System Market Soars: USD 148M in 2024 to USD 1134M by 2031 at 34.3% CAGR | Valuates Reports

Microphysiological System Market is Segmented by Type (Human Organ and Tissue Models, Disease Models, Non-Human Species Models), by Application...

Copolyester Market to Reach $3158 Million by 2031, Driven by Demand in Automotive, Medical, and Packaging Sectors | Valuates Reports

Copolyester Market to Reach $3158 Million by 2031, Driven by Demand in Automotive, Medical, and Packaging Sectors | Valuates Reports

Copolyester Market is Segmented by Type (PET, PCTG, PCTA, PETG, PCT), by Application (Automobile, Electric Cables and Hoses, Medical). The Global...

More Releases From This Source

Explore

Pharmaceuticals

Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.